NJ Medication-Assisted Treatment Centers of Excellence

MAT Provider Hotline: 866-221-2611 (Monday to Friday - 8am to 8pm) Northern COE: coe@njms.rutgers.edu Southern COE: southernnjcoe@rowan.edu The New Jersey Medication-Assisted Treatment Centers of Excellence recmmends that medication-assisted treatment (MAT) providers follow these best practices during the COVID-pandemic to maintain patient safety and continuity of care.

Centers for Medicare & Medicaid Services

WEBSITE CMS Announces Relief for Clinicians, Providers, Hospitals and Facilities Participating in Quality Reporting Programs in Response to COVID-19.

US Department Health & Human Services / Health Information Privacy

WEBSITE Notification of Enforcement Discretion for telehealth remote communications during the COVID-19 nationwide public health emergency.

Telehealth Learning Series

WEBSITE Telehealth Learning & Discussion Series for SUD Tx and Recovery Support Providers from the ATTC Network & partners.

National Council for Behavioral Health

WEBSITE

Calling all medical directors – we are hosting a series of COVID-19 discussion calls to foster peer engagement, resource sharing and conversation around navigating the pandemic.

During this time of uncertainty, patients may be experiencing heightened emotional distress due to the effects of COVID-19 on their families and communities. How can you maximize your impact?

Designed with you in mind, our calls will connect you with like-minded peers and facilitate the exchange of tools, resources and information to help you, your organization and your patients navigate this challenging time.

Join us for our next call on Thursday, April 2, at 11 a.m. ET, to receive the latest updates on a variety of COVID-19 issues, while engaging colleagues in an interactive setting.

Our calls are presented by the National Council Medical Director Institute (MDI) and facilitated by Joe Parks, M.D., an MDI co-chair and the National Council’s vice president of practice improvement and medical director.

DEA and SAMHSA Buprenorphine and Telemedicine COVID-19 Guidance

PDF DOCUMENT In light of the coronavirus pandemic, the Drug Enforcement Administration (DEA) has partnered with SAMHSA to ensure authorized practitioners may admit and treat new patients with opioid use disorder (OUD) during the public health emergency.

NJ Medication-Assisted Treatment Centers of Excellence

MAT Provider Hotline: 866-221-2611 (Monday to Friday - 8am to 8pm) Northern COE: coe@njms.rutgers.edu Southern COE: southernnjcoe@rowan.edu The New Jersey Medication-Assisted Treatment Centers of Excellence recmmends that medication-assisted treatment (MAT) providers follow these best practices during the COVID-pandemic to maintain patient safety and continuity of care.

Centers for Medicare & Medicaid Services

WEBSITE CMS Announces Relief for Clinicians, Providers, Hospitals and Facilities Participating in Quality Reporting Programs in Response to COVID-19.

US Department Health & Human Services / Health Information Privacy

WEBSITE Notification of Enforcement Discretion for telehealth remote communications during the COVID-19 nationwide public health emergency.

Telehealth Learning Series

WEBSITE Telehealth Learning & Discussion Series for SUD Tx and Recovery Support Providers from the ATTC Network & partners.

National Council for Behavioral Health

WEBSITE

Calling all medical directors – we are hosting a series of COVID-19 discussion calls to foster peer engagement, resource sharing and conversation around navigating the pandemic.

During this time of uncertainty, patients may be experiencing heightened emotional distress due to the effects of COVID-19 on their families and communities. How can you maximize your impact?

Designed with you in mind, our calls will connect you with like-minded peers and facilitate the exchange of tools, resources and information to help you, your organization and your patients navigate this challenging time.

Join us for our next call on Thursday, April 2, at 11 a.m. ET, to receive the latest updates on a variety of COVID-19 issues, while engaging colleagues in an interactive setting.

Our calls are presented by the National Council Medical Director Institute (MDI) and facilitated by Joe Parks, M.D., an MDI co-chair and the National Council’s vice president of practice improvement and medical director.

DEA and SAMHSA Buprenorphine and Telemedicine COVID-19 Guidance

PDF DOCUMENT In light of the coronavirus pandemic, the Drug Enforcement Administration (DEA) has partnered with SAMHSA to ensure authorized practitioners may admit and treat new patients with opioid use disorder (OUD) during the public health emergency.

NJ Medication-Assisted Treatment Centers of Excellence

MAT Provider Hotline: 866-221-2611 (Monday to Friday - 8am to 8pm) Northern COE: coe@njms.rutgers.edu Southern COE: southernnjcoe@rowan.edu The New Jersey Medication-Assisted Treatment Centers of Excellence recmmends that medication-assisted treatment (MAT) providers follow these best practices during the COVID-pandemic to maintain patient safety and continuity of care.

Centers for Medicare & Medicaid Services

WEBSITE CMS Announces Relief for Clinicians, Providers, Hospitals and Facilities Participating in Quality Reporting Programs in Response to COVID-19.

US Department Health & Human Services / Health Information Privacy

WEBSITE Notification of Enforcement Discretion for telehealth remote communications during the COVID-19 nationwide public health emergency.

Telehealth Learning Series

WEBSITE Telehealth Learning & Discussion Series for SUD Tx and Recovery Support Providers from the ATTC Network & partners.

National Council for Behavioral Health

WEBSITE

Calling all medical directors – we are hosting a series of COVID-19 discussion calls to foster peer engagement, resource sharing and conversation around navigating the pandemic.

During this time of uncertainty, patients may be experiencing heightened emotional distress due to the effects of COVID-19 on their families and communities. How can you maximize your impact?

Designed with you in mind, our calls will connect you with like-minded peers and facilitate the exchange of tools, resources and information to help you, your organization and your patients navigate this challenging time.

Join us for our next call on Thursday, April 2, at 11 a.m. ET, to receive the latest updates on a variety of COVID-19 issues, while engaging colleagues in an interactive setting.

Our calls are presented by the National Council Medical Director Institute (MDI) and facilitated by Joe Parks, M.D., an MDI co-chair and the National Council’s vice president of practice improvement and medical director.

DEA and SAMHSA Buprenorphine and Telemedicine COVID-19 Guidance

PDF DOCUMENT In light of the coronavirus pandemic, the Drug Enforcement Administration (DEA) has partnered with SAMHSA to ensure authorized practitioners may admit and treat new patients with opioid use disorder (OUD) during the public health emergency.

NJ Department of Health — COVID-19 Updates & Resources

WEBSITE Resource pages includes guidance for travelers, resources for healthcare providers, and informational materials in multiple languages fro COVID-19 including New Jersey's COVID-19 Informational Hub.

211 Get Connected / Get Help — Assistance with Essential Services

WEBSITE If assistance is needed finding food, paying housing bills or other essentila services, dial 211 to speak to someone who can help.

The NJ Poison Control Center and 211- Provides information on COVID-19

Call: 2-1-1 Call (24/7): 1-800-962-1253 Text: NJCOVID to 898-211 Visit nj.gov/health for additional information
Notification of Enforcement Discretion for telehealth remote communications during the COVID-19 nationwide public health emergency.

NJ Resources For Narcan

Call or text 877-4Narcan (877-462-7226) NJ Harm Reduction Coalition Please call or text 877-4Narcan (877-462-7226) to have free Naloxone mailed anywhere in New Jersey! Access to Narcan through The Robert Wood Johnson's Medical School and The RWJBarnabas Health Institute for Prevention and Recovery For more information, call 732-235-4341, email PreventOverdose@rwjms.rutgers.edu, or visit their website.

Screenings for NJ Residences

WEBSITE NJHelps can screen you for programs that provide eligible residents help with food and nutrition, finances, health, child care, housing, utility costs, tax relief, and career guidance. This free and easy-to-use, web-based service is designed to walk you through basic eligibility criteria online and enable you to anonymously answer simple questions about your family, your income, and your situation.

Legal Assistance — Community Law Project

WEBSITE

NJ Foodbanks — View List of All NJ Food Banks Near You

WEBSITE Food banks in NJ are amazing organizations that are mostly run by volunteers with big hearts with one goal only, to help those in need.

NJ Hope Line For Suicide Prevention

1-855-654-6735 NJ Hope Line for Suicide Prevention Our specialists are available for confidential telephone counseling and support 24 hours a day, 7 day per week. You’re not alone … we are only a phone call away.

Rutgers University Behavioral Health Care Call Center

WEBSITE 1-800-969-5300 A center that connects callers to the appropriate division of statewide behavioral health services system.

Reach NJ — New Jersey Department on Human Services

1-844-732-2465 Webiste ReachNJ connects individuals who need counseling to live, trained addiction experts who answer the 24-hours-a-day, 7-days-a-week hotline and get callers help, regardless of their insurance status.

County Specific Directory of All Local NJ Health Departments

PDF DIRECTORY

NJ Department of Education COVID-19 Updates

WEBSITE The New Jersey Department of Education is deeply committed to supporting its students, families, and educators as we work together to reduce the spread of COVID-19. The guidance and resources provided below come from national educational leaders, researchers, and teachers with content area expertise. The Department recognizes that “schooling” cannot continue as usual and that schools and educators will be addressing the diverse needs of their students in different ways.

NJ Department of Military and Veterans Affairs- Call Center & Hotline Information

WEBSITE

The State of New Jersey Department of Law and Public Saftey Office of the Attorney General — NJ CARES

WEBSITE NJ CARES wants to make sure we’re doing everything we can to provide you with up-to-date information on treatment and recovery services that remain accessible to those who need them. With help from our partners, we’ve compiled these lists of available resources. Please share them with those who may feel alone during this crisis and help them stay connected.

NJ Department of Human Services — COVID-19 Full Updates & Resource List

WEBSITE Novel Coronavirus Information — Policies and Resources Links

AmmonLabs COVID-19 Testing

PDF Get tested for COVID-19 antibody today. Schedule an appointment at AmmonTesting.com or call 908-862-4404. Appointments available MON–FRI 8AM – 4PM Ammon participates with most major insurance plans. Physician prescription required. Locations:

• 1622 South Wood Ave. Linden, NJ 07036
• 9 Hospital Drive, Suite C28, Toms River, NJ 08755

The State of New Jersey Department of Children and Families

WEBSITE This information provides links and resources on publications regarding services being provided during the COVID-19 Coronavirus pandemic which are available for downloading as either PDF (ideal for print) or JPG (ideal for social media). Resources pertain to families, adolescents, women, providers, stakeholders and advocacy.

NJ Medication-Assisted Treatment Centers of Excellence

MAT Provider Hotline: 866-221-2611 (Monday to Friday - 8am to 8pm) Northern COE: coe@njms.rutgers.edu Southern COE: southernnjcoe@rowan.edu The New Jersey Medication-Assisted Treatment Centers of Excellence recmmends that medication-assisted treatment (MAT) providers follow these best practices during the COVID-pandemic to maintain patient safety and continuity of care.

Centers for Medicare & Medicaid Services

WEBSITE CMS Announces Relief for Clinicians, Providers, Hospitals and Facilities Participating in Quality Reporting Programs in Response to COVID-19.

US Department Health & Human Services / Health Information Privacy

WEBSITE Notification of Enforcement Discretion for telehealth remote communications during the COVID-19 nationwide public health emergency.

Telehealth Learning Series

WEBSITE Telehealth Learning & Discussion Series for SUD Tx and Recovery Support Providers from the ATTC Network & partners.

National Council for Behavioral Health

WEBSITE

Calling all medical directors – we are hosting a series of COVID-19 discussion calls to foster peer engagement, resource sharing and conversation around navigating the pandemic.

During this time of uncertainty, patients may be experiencing heightened emotional distress due to the effects of COVID-19 on their families and communities. How can you maximize your impact?

Designed with you in mind, our calls will connect you with like-minded peers and facilitate the exchange of tools, resources and information to help you, your organization and your patients navigate this challenging time.

Join us for our next call on Thursday, April 2, at 11 a.m. ET, to receive the latest updates on a variety of COVID-19 issues, while engaging colleagues in an interactive setting.

Our calls are presented by the National Council Medical Director Institute (MDI) and facilitated by Joe Parks, M.D., an MDI co-chair and the National Council’s vice president of practice improvement and medical director.

DEA and SAMHSA Buprenorphine and Telemedicine COVID-19 Guidance

PDF DOCUMENT In light of the coronavirus pandemic, the Drug Enforcement Administration (DEA) has partnered with SAMHSA to ensure authorized practitioners may admit and treat new patients with opioid use disorder (OUD) during the public health emergency.

NJ Medication-Assisted Treatment Centers of Excellence

MAT Provider Hotline: 866-221-2611 (Monday to Friday - 8am to 8pm) Northern COE: coe@njms.rutgers.edu Southern COE: southernnjcoe@rowan.edu The New Jersey Medication-Assisted Treatment Centers of Excellence recmmends that medication-assisted treatment (MAT) providers follow these best practices during the COVID-pandemic to maintain patient safety and continuity of care.

Centers for Medicare & Medicaid Services

WEBSITE CMS Announces Relief for Clinicians, Providers, Hospitals and Facilities Participating in Quality Reporting Programs in Response to COVID-19.

US Department Health & Human Services / Health Information Privacy

WEBSITE Notification of Enforcement Discretion for telehealth remote communications during the COVID-19 nationwide public health emergency.

Telehealth Learning Series

WEBSITE Telehealth Learning & Discussion Series for SUD Tx and Recovery Support Providers from the ATTC Network & partners.

National Council for Behavioral Health

WEBSITE

Calling all medical directors – we are hosting a series of COVID-19 discussion calls to foster peer engagement, resource sharing and conversation around navigating the pandemic.

During this time of uncertainty, patients may be experiencing heightened emotional distress due to the effects of COVID-19 on their families and communities. How can you maximize your impact?

Designed with you in mind, our calls will connect you with like-minded peers and facilitate the exchange of tools, resources and information to help you, your organization and your patients navigate this challenging time.

Join us for our next call on Thursday, April 2, at 11 a.m. ET, to receive the latest updates on a variety of COVID-19 issues, while engaging colleagues in an interactive setting.

Our calls are presented by the National Council Medical Director Institute (MDI) and facilitated by Joe Parks, M.D., an MDI co-chair and the National Council’s vice president of practice improvement and medical director.

DEA and SAMHSA Buprenorphine and Telemedicine COVID-19 Guidance

PDF DOCUMENT In light of the coronavirus pandemic, the Drug Enforcement Administration (DEA) has partnered with SAMHSA to ensure authorized practitioners may admit and treat new patients with opioid use disorder (OUD) during the public health emergency.

NJ Medication-Assisted Treatment Centers of Excellence

MAT Provider Hotline: 866-221-2611 (Monday to Friday - 8am to 8pm) Northern COE: coe@njms.rutgers.edu Southern COE: southernnjcoe@rowan.edu The New Jersey Medication-Assisted Treatment Centers of Excellence recmmends that medication-assisted treatment (MAT) providers follow these best practices during the COVID-pandemic to maintain patient safety and continuity of care.

Centers for Medicare & Medicaid Services

WEBSITE CMS Announces Relief for Clinicians, Providers, Hospitals and Facilities Participating in Quality Reporting Programs in Response to COVID-19.

US Department Health & Human Services / Health Information Privacy

WEBSITE Notification of Enforcement Discretion for telehealth remote communications during the COVID-19 nationwide public health emergency.

Telehealth Learning Series

WEBSITE Telehealth Learning & Discussion Series for SUD Tx and Recovery Support Providers from the ATTC Network & partners.

National Council for Behavioral Health

WEBSITE

Calling all medical directors – we are hosting a series of COVID-19 discussion calls to foster peer engagement, resource sharing and conversation around navigating the pandemic.

During this time of uncertainty, patients may be experiencing heightened emotional distress due to the effects of COVID-19 on their families and communities. How can you maximize your impact?

Designed with you in mind, our calls will connect you with like-minded peers and facilitate the exchange of tools, resources and information to help you, your organization and your patients navigate this challenging time.

Join us for our next call on Thursday, April 2, at 11 a.m. ET, to receive the latest updates on a variety of COVID-19 issues, while engaging colleagues in an interactive setting.

Our calls are presented by the National Council Medical Director Institute (MDI) and facilitated by Joe Parks, M.D., an MDI co-chair and the National Council’s vice president of practice improvement and medical director.

DEA and SAMHSA Buprenorphine and Telemedicine COVID-19 Guidance

PDF DOCUMENT In light of the coronavirus pandemic, the Drug Enforcement Administration (DEA) has partnered with SAMHSA to ensure authorized practitioners may admit and treat new patients with opioid use disorder (OUD) during the public health emergency.